Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial

Transplant Proc. 1996 Oct;28(5):2811.

Authors

C Pouteil-Noble¹, F Megas, F Chapuis, S Bosshard, C Colin, A Hadj-Aissa, N Pozet, X Martin, N Lefrançois, J L Garnier, M Aymard, J L Touraine

Affiliation

¹ Nephrology-Transplantation Unit, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.

PMID: 8908072

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Acyclovir / therapeutic use*
Antiviral Agents / therapeutic use*
Cytomegalovirus Infections / classification
Cytomegalovirus Infections / epidemiology
Cytomegalovirus Infections / prevention & control*
Follow-Up Studies
Ganciclovir / therapeutic use*
Graft Rejection / epidemiology
Graft Survival
Humans
Incidence
Kidney Transplantation*
Placebos
Postoperative Complications*
Probability

Substances

Antiviral Agents
Placebos
Ganciclovir
Acyclovir